ArthNow Logo
ArthNow
•2 min read•
✦Reported by Moneycontrol

Eldorado Agritech halves IPO size to Rs 504 crore; promoters to sell Rs 330 crore stake

Eldorado Agritech halves IPO size to Rs 504 crore; promoters to sell Rs 330 crore stake
Source: Moneycontrol

Executive Brief • Key Highlights

Fast factual intelligence distilled for busy investors, executives, and answer bots:

  • ✓Eldorado Agritech cut its IPO size to Rs 504 crore, as shown in a notice on November 19.
  • ✓The company plans to raise Rs 174 crore through fresh shares, while promoters will sell a Rs 330 crore stake.
  • ✓They said this change follows new guidance from the market regulator SEBI.

Story at a Glance

Category
Indian Markets
Reported By
Moneycontrol
Reading Speed
2 Minute(s)
Market Focus
India Economy

Market Mastery

Webinar by Vishal Malkan

Find the weak links

in your portfolio by Vishal Malkan

Hyderabad-based seeds and agrochemicals manufacturer Eldorado Agritech has decided to halve the size of its proposed initial public offering (IPO) to Rs 504 crore, according to a notice to investors published on November 19.

Under the revised IPO structure, the company plans to raise Rs 174 crore through a fresh issue of equity shares, while the remaining Rs 330 crore will be raised through an offer-for-sale (OFS) by its promoters.

Promoter Srinivasa Rao Linga and his wife, Usha Rani Papineni, will sell shares worth Rs 250 crore and Rs 80 crore, respectively, through the OFS.

🔒
Premium Content

Unlock the Full Story with ArthNow Premium

To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.

✓ Full Unabridged Reports✓ Executive Audio Briefs✓ 100% Ad-Free Reading
Verified Publication Source

Moneycontrol

Read the full, original unfiltered story directly on the publisher's portal.

Visit Original Article

This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.